Long-Term Follow-Up of Patients Who Experienced Graft Failure Postallogeneic Progenitor Cell Transplantation. Results of a Single Institution Analysis

Biology of Blood and Marrow Transplantation

Volumn 14, Issue 8, 2008, Pages 859-866

  Rondón, Gabriela ^a   Saliba, Rima M ^a   Khouri, Issa ^a   Giralt, Sergio ^a   Chan, Kawah ^b   Jabbour, Elias ^a   McMannis, John ^a   Champlin, Richard ^a   Shpall, Elizabeth ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b TEXAS TRANSPLANT INSTITUTE   (United States)

Author keywords

Allogeneic stem cell transplantation; Graft failure; Treatment

Indexed keywords

CYCLOSPORIN; TACROLIMUS;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ALLOGENEIC STEM CELL TRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; CHILD; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; ENGRAFTMENT; FEMALE; FOLLOW UP; GRAFT FAILURE; GRAFT VERSUS HOST REACTION; HUMAN; LONG TERM CARE; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; MYELOPROLIFERATIVE DISORDER; NEUTROPHIL COUNT; OVERALL SURVIVAL; PREDICTION; PROGNOSIS; RETROSPECTIVE STUDY; TREATMENT OUTCOME; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; NEUTROPHILS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 47249088744     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2008.05.005     Document Type: Article

References (29)

1. Armitage J. Bone marrow transplantation. N Engl J Med 330 (1994) 827-838
2. Tabbara I., Zimmermann K., Morgan C., and Nahleh Z. Allogeneic hematopoietic cell transplantation; complications and results. Arch Intern Med 162 (2002) 1558-1562
3. Thomas E.D., Fefer A., Buckner C.D., and Storb R. Current status of bone marrow transplantation for aplastic anemia and acute leukemia. Blood 49 (1977) 671-681
4. Storb R. Graft rejection and graft versus host disease in marrow transplantation. Transplant Proc 23 1 Pt 3 (1989) 2915-2918
5. Storb R., Thomas E.D., Buckner C.D., et al. Marrow transplantation for aplastic anemia. Semin Hematol 21 (1984) 27-35
6. Weisdorf D., Verfaillie C.M., Davies S.M., et al. Hematopoietic growth factors for graft failure after bone marrow transplantation: a randomized trial of granulocyte macrophage colony-stimulating factor (GM-CSF) versus sequential GM-CSF plus granulocyte-CSF. Blood 85 (1995) 3452-3456
7. Davies S.M., Weisdorf D.J., Haake R.J., et al. Second infusion of bone marrow for treatment of graft failure after allogeneic bone marrow transplantation. Bone Marrow Transplant 4 (1994) 73-77
8. Remberger M., Ringden O., Ljungman P., et al. Booster marrow or blood cells for graft failure after allogeneic bone marrow transplantation. Bone Marrow Transplant 22 (1998) 73-78
9. Mehta J., Powles R., Singhal S., et al. Outcome of autologous rescue after failed engraftment of allogeneic marrow. Bone Marrow Transplant 17 (1996) 213-217
10. Woodard P., Tong X., Richardson S., et al. Etiology and outcome of graft failure in pediatric hematopoietic stem cell transplant recipients. J Pediatr Hematol Oncol 25 (2003) 955-959
11. Nemunaitis J., Singer J.W., Buckner C.D., et al. Use of recombinant granulocyte-macrophage colony-stimulating factor in graft failure after bone marrow transplantation. Blood 76 (1990) 245-253
12. Grandage V.L., Cornish J.M., Pamphilon D.H., et al. Second allogeneic bone marrow transplants from unrelated donors for graft failure following initial unrelated bone marrow transplantation. Bone Marrow Transplant 21 (1998) 687-690
13. Guardiola P., Kuentz M., Garban F., et al. Second early allogeneic stem cell transplantations for graft failure in acute leukemia, chronic myeloid leukaemia and aplastic anemia. French Society of Bone Marrow Transplantation. Br J Haematol 111 (2000) 292-302
14. Jabbour E., Rondon G., Anderlini P., et al. Treatment of donor graft failure with nonmyeloablative conditioning of fludarabine, antithymocyte globulin and a second allogeneic hematopoietic transplantation. Bone Marrow Transplant 40 (2007) 431-435
15. Chan K.W., Grimley M.S., Taylor C., and Wall D.A. Early identification and management of graft failure after unrelated CB transplantation. Bone Marrow Transplant 10 (2008) 1-7
16. Heinzelmann F., Lang P.J., Ottinger H., et al. Immunosuppressive total lymphoid irradiation-based reconditioning regimens enable engraftment after graft rejection or graft failure in patients treated with allogeneic hematopoietic stem cell transplantation. Int J Radiat Oncol Biol Phys 70 (2008) 523-528
17. Lang P., Mueller I., Greil J., et al. Retransplantation with stem cells from mismatched related donors after graft rejection in pediatric patients. Blood Cells Mol Dis 40 (2008) 33-39
18. Chen J., Law P., and Ball E. Failure of engraftment. In: Ball E., Lister J., and Law P. (Eds). Hematopoietic Stem Cell Therapy. 1st ed. (2000), Churchill-Livingston, Philadelphia 521-531
19. Champlin R., Khouri I., Kornblau S., Molldrem, and Giralt S. Reinventing bone marrow transplantation. Nonmyeloablative preparative regimens and induction of graft-vs-malignancy effect. Oncology 13 (1999) 621-628
20. Antin J.H., Childs R., Filipovich A.H., et al. Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: recommendations from a workshop at the 2001 Tandem Meetings of the International Bone Marrow Transplant Registry and the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transplant 7 (2001) 473-485
21. Kaplan E.L., and Meier P. Nonparametric estimator from incomplete observations. J Am Stat Assoc 53 (1958) 457-481
22. Cox D.R. Regression models and life tables (with discussion). J R Stat Soc B 34 (1972) 187
23. Storb R., Prentice R.L., Thomas E.D., et al. Factors associated with graft rejection after HLA identical marrow transplantation for aplastic anemia. Br J Haematol 55 (1983) 573-585
24. Kernan N.A., Bartsch G., Ash R.C., et al. Retrospective analysis of 462 unrelated marrow transplants facilitated by the National Marrow Donor Program (NMDP) for the treatment of acquired and congenital disorders of the lymphohematopoietic system and congenital metabolic disorders. N Engl J Med 328 (1993) 593-602
25. Baron F., Baker J.E., Storb R., et al. Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after non myeloablative conditioning. Blood 104 (2004) 2254-2262
26. Ballen K.K., Colvin G., Porter D., and Quesenberry P.J. Low dose total body irradiation followed by allogeneic lymphocyte infusion for refractory hematologic malignancy-an updated review. Leukemia Lymphoma 45 (2004) 905-910
27. Ballen K.K., Becker P.S., Emmons R.V., et al. Low-dose total body irradiation followed by allogeneic lymphocyte infusion may induce remission in patients with refractory hematologic malignancy. Blood 100 (2002) 442-450
28. Hachem R.Y., Hicks K., Huen A., and Raad I. Myelosuppression and serotonin syndrome associated with concurrent use of linezolid and selective serotonin reuptake inhibitors in bone marrow transplant recipients. Clin Infect Dis 37 (2003) e8-e11
29. Mehta J., Powles R., Singhal S., et al. Early identification of patients at risk of death because of infections, hemorrhage, or graft failure after allogeneic bone marrow transplantation on the basis of the leukocyte count. Bone Marrow Transplant 19 (1997) 349-355